SkinHealth Systems Inc. APIC, Share-based Payment Arrangement, Increase for Cost Recognition
SkinHealth Systems Inc. (SKIN) reported APIC, Share-based Payment Arrangement, Increase for Cost Recognition of $2.90 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Shareholders' Equity
us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue · last filed 2026-08-06
- SkinHealth Systems Inc. apic, share-based payment arrangement, increase for cost recognition for the quarter ending 2026-06-30 was $2.90M, a 45.46% decline year-over-year.
- SkinHealth Systems Inc. apic, share-based payment arrangement, increase for cost recognition for the quarter ending 2026-03-31 was $2.08M, a 40.19% decline year-over-year.
- SkinHealth Systems Inc. apic, share-based payment arrangement, increase for cost recognition for the quarter ending 2025-09-30 was $2.46M, a 68.17% decline year-over-year.
- SkinHealth Systems Inc. apic, share-based payment arrangement, increase for cost recognition for the quarter ending 2025-06-30 was $5.31M, a 18.31% decline year-over-year.
- SkinHealth Systems Inc. apic, share-based payment arrangement, increase for cost recognition for fiscal 2025 was $14.82M, a 44.47% decline from fiscal 2024.
- SkinHealth Systems Inc. apic, share-based payment arrangement, increase for cost recognition for fiscal 2024 was $26.70M, a 18.42% increase from fiscal 2023.
- SkinHealth Systems Inc. apic, share-based payment arrangement, increase for cost recognition for fiscal 2023 was $22.54M, a 20.88% decline from fiscal 2022.
- SkinHealth Systems Inc. apic, share-based payment arrangement, increase for cost recognition for fiscal 2022 was $28.50M, a 129.47% increase from fiscal 2021.
| Period end | APIC, Share-based Payment Arrangement, Increase for Cost Recognition 3 month | APIC, Share-based Payment Arrangement, Increase for Cost Recognition 6 month | APIC, Share-based Payment Arrangement, Increase for Cost Recognition 9 month | APIC, Share-based Payment Arrangement, Increase for Cost Recognition 12 month |
|---|---|---|---|---|
| 2026-06-30 | $2.90M 10-Q · filed 2026-08-06 | $4.97M derived: sum of 2 quarters · filed 2026-08-06 | ||
| 2026-03-31 | $2.08M 10-Q · filed 2026-08-06 | |||
| 2025-12-31 | $14.82M 10-K · filed 2026-03-12 | |||
| 2025-09-30 | $2.46M 10-Q · filed 2025-11-06 | $7.76M derived: sum of 2 quarters · filed 2026-08-06 | $11.24M derived: sum of 3 quarters · filed 2026-08-06 | |
| 2025-06-30 | $5.31M 10-Q · filed 2026-08-06 | $8.78M derived: sum of 2 quarters · filed 2026-08-06 | ||
| 2025-03-31 | $3.48M 10-Q · filed 2026-08-06 | |||
| 2024-12-31 | $26.70M 10-K · filed 2026-03-12 | |||
| 2024-09-30 | $7.71M 10-Q · filed 2025-11-06 | $14.21M derived: sum of 2 quarters · filed 2025-11-06 | $20.85M derived: sum of 3 quarters · filed 2025-11-06 | |
| 2024-06-30 | $6.50M 10-Q · filed 2025-11-06 | $13.13M derived: sum of 2 quarters · filed 2025-11-06 | ||
| 2024-03-31 | $6.64M 10-Q · filed 2025-11-06 | |||
| 2023-12-31 | $22.54M 10-K · filed 2026-03-12 | |||
| 2023-09-30 | $8.19M 10-Q · filed 2024-11-12 | $16.71M derived: sum of 2 quarters · filed 2024-11-12 | $20.29M derived: sum of 3 quarters · filed 2024-11-12 | |
| 2023-06-30 | $8.52M 10-Q · filed 2024-11-12 | $12.10M derived: sum of 2 quarters · filed 2024-11-12 | ||
| 2023-03-31 | $3.58M 10-Q · filed 2024-11-12 | |||
| 2022-12-31 | $28.50M 10-K · filed 2025-03-12 | |||
| 2022-09-30 | $7.45M 10-Q · filed 2023-11-14 | $13.83M derived: sum of 2 quarters · filed 2023-11-14 | $20.88M derived: sum of 3 quarters · filed 2023-11-14 | |
| 2022-06-30 | $6.38M 10-Q · filed 2023-11-14 | $13.43M derived: sum of 2 quarters · filed 2023-11-14 | ||
| 2022-03-31 | $7.05M 10-Q · filed 2023-11-14 | |||
| 2021-12-31 | $12.42M 10-K · filed 2024-03-12 | |||
| 2021-09-30 | $5.08M 10-Q · filed 2022-11-09 | $8.59M derived: sum of 2 quarters · filed 2022-11-09 | $8.62M derived: sum of 3 quarters · filed 2022-11-09 | |
| 2021-06-30 | $3.51M 10-Q · filed 2022-11-09 | $3.54M derived: sum of 2 quarters · filed 2022-11-09 | ||
| 2021-03-31 | $34.00K 10-Q · filed 2022-11-09 | |||
| 2020-12-31 | $363.00K 10-K · filed 2023-03-01 | |||
| 2020-09-30 | $76.00K 10-Q · filed 2021-11-12 | $300.00K derived: sum of 2 quarters · filed 2021-11-12 | $326.00K derived: sum of 3 quarters · filed 2021-11-12 | |
| 2020-06-30 | $224.00K 10-Q · filed 2021-11-12 | $250.00K derived: sum of 2 quarters · filed 2021-11-12 | ||
| 2020-03-31 | $26.00K 10-Q · filed 2021-11-12 | |||
| 2019-12-31 | $103.00K 10-K · filed 2022-03-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| LENSAR, Inc. (LNSR) | United States | $0.087B | 2.02 |
| Microbot Medical Inc. (MBOT) | $0.089B | -7.97 | |
| Pulmonx Corp (LUNG) | United States | $0.082B | -1.16 |
| RenovoRx, Inc. (RNXT) | United States | $0.076B | -3.62 |
| FRACTYL HEALTH, INC. (GUTS) | United States | $0.075B | -1.18 |
| CVRx, Inc. (CVRX) | United States | $0.067B | -2.62 |
| DarioHealth Corp. (DRIO) | $0.066B | -1.39 | |
| TELA Bio, Inc. (TELA) | United States | $0.057B | -0.82 |
| Xtant Medical Holdings, Inc. (XTNT) | United States | $0.053B | |
| Apyx Medical Corp (APYX) | United States | $0.120B | -21.85 |